These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 17620942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E, Katoh M, Wiethoff AJ, Buecker A, Botnar RM, Parsons EC, Guenther RW.
    Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E, Fausten B, Kinzel S, Wiethoff AJ, Botnar RM, Graham PB, Haller S, Katoh M, Parsons EC, Manning WJ, Busch T, Günther RW, Buecker A.
    Circulation; 2005 Jul 19; 112(3):396-9. PubMed ID: 16009790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
    Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Weisskoff RM, Graham PB, Manning WJ, Günther RW.
    Circulation; 2005 Mar 22; 111(11):1377-82. PubMed ID: 15738354
    [Abstract] [Full Text] [Related]

  • 7. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC.
    Invest Radiol; 2009 Nov 22; 44(11):697-704. PubMed ID: 19809344
    [Abstract] [Full Text] [Related]

  • 8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M, Haage P, Wiethoff AJ, Günther RW, Bücker A, Tacke J, Spuentrup E.
    Invest Radiol; 2009 Mar 22; 44(3):146-50. PubMed ID: 19151606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA.
    Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stracke CP, Katoh M, Wiethoff AJ, Parsons EC, Spangenberg P, Spüntrup E.
    Stroke; 2007 May 13; 38(5):1476-81. PubMed ID: 17379818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 13; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
    Spuentrup E, Wiethoff AJ, Parsons EC, Spangenberg P, Stracke CP.
    Eur J Radiol; 2010 Jun 13; 74(3):445-52. PubMed ID: 19394183
    [Abstract] [Full Text] [Related]

  • 18. Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus.
    Nair SA, Kolodziej AF, Bhole G, Greenfield MT, McMurry TJ, Caravan P.
    Angew Chem Int Ed Engl; 2008 Jun 13; 47(26):4918-21. PubMed ID: 18496805
    [No Abstract] [Full Text] [Related]

  • 19. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A, Pfeuffer J, Mishra R, Engelmann J, Mishra AK, Ugurbil K, Logothetis NK.
    Bioconjug Chem; 2006 Jun 13; 17(3):773-80. PubMed ID: 16704217
    [Abstract] [Full Text] [Related]

  • 20. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging.
    Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA.
    Atherosclerosis; 2005 Sep 13; 182(1):79-85. PubMed ID: 16115477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.